AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode

Update: 2022-07-22

Description

Today on All Access we discuss Build Back Better and its Impact on the Generic and Biosimilar Industry. My guests are Kurt Karst, Director at Hyman Phelps & McNamara, Rachel Turow, Associate General Counsel for Regulatory Law and Policy and the Head of U.S. Regulatory Policy at Teva Pharmaceuticals, and Rachel Goode, Senior Vice President for Biosimilars Patents and Legal at Fresenius Kabi.

Comments

In Channel

AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode

2022-07-2225:58

AAM All Access - Mary Beth Powers of CMMB

2022-06-1618:45

AAM All Access - Managing Drug Shortages

2022-05-1838:32

AAM All Access - Thomas Tighe

2022-03-2828:23

AAM All Access - Alok Sonig

2022-03-0819:06

AAM All Access - Kendra Davenport

2021-12-1620:41

AAM All Access - Christopher Palombo

2021-11-0924:27

AAM All Access - Monét Stanford & Lisa Parks

2021-10-2117:42

AAM All Access - Robert Pollock

2021-09-2436:00

AAM All Access - Doug Long

2021-09-0126:20

AAM All Access - Jeff Watson

2021-07-2822:09

AAM All Access - Avik Roy

2021-07-1950:11

AAM All Access - Anthony Principi

2021-07-0729:48

AAM All Access - Bob Billings

2021-06-0125:26

AAM All Access - Vinita Gupta

2021-04-1427:50

00:00

AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode

#box-pro-ellipsis-176101922771177{-webkit-line-clamp:2;}AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode

AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode

AAM All Access

AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode